RE.DOCTOR LLC 获得 ISO 13485 认证

RE.DOCTOR LLC 获得 ISO 13485 认证，彰显其对医疗器械开发质量的承诺。

RE.DOCTOR LLC, a leading developer of innovative medical devices, today announced it has achieved ISO 13485:2016 certification. This internationally recognized standard signifies the company’s commitment to the highest quality management systems in the design, development, and production of medical devices.

“Obtaining ISO 13485 certification is a significant milestone for RE.DOCTOR,” said Simon Halliday, CEO of RE.DOCTOR LLC. “This rigorous certification process demonstrates our unwavering dedication to providing safe, reliable, and effective medical devices to patients worldwide. We are committed to continuous improvement and exceeding the expectations of healthcare professionals and patients alike.”

加强医疗器械开发的质量管理

ISO 13485 认证表明，RE.DOCTOR 已经实施了符合医疗器械行业特殊要求的健全的质量管理体系 (QMS)。该质量管理体系确保对医疗器械生命周期的所有方面（从最初的概念和设计到生产、分销和上市后监督）采取结构化和受控的方法。

“Our ISO 13485 certification assures stakeholders that our medical devices are developed and manufactured according to the highest quality standards,” commented Halliday. “This certification strengthens our partnerships with regulatory bodies, healthcare providers, and distributors, allowing us to bring our innovative medical devices to market more efficiently.”

为患者和医护人员带来的益处

RE.DOCTOR’s ISO 13485 certification offers several key benefits for patients and healthcare professionals:

• 提高患者安全： 健全的质量管理体系有助于最大限度地降低与医疗器械开发和生产相关的风险，最终提高患者的安全。
• 提高设备质量和性能： The structured approach ensures consistent quality and performance of RE.DOCTOR’s medical devices.
• 增强监管合规性： The certification demonstrates RE.DOCTOR’s commitment to meeting regulatory requirements for medical devices.
• 增强医疗服务提供者的信心： 通过选择 ISO 13485 认证的医疗器械，医疗服务提供者可以确信他们使用的是安全有效的产品。

对质量的持续承诺

RE.DOCTOR 将 ISO 13485 认证视为持续改进的基础。公司致力于维护并不断加强其质量管理体系，以确保始终达到最高质量标准。

“We are dedicated to exceeding industry standards and delivering the best possible outcomes for patients,” concluded Halliday. “Our ISO 13485 certification is a testament to this commitment, and we look forward to leveraging our robust QMS to develop and deliver even more innovative medical devices in the future.”